SCHEMBL4566402

SCHEMBL4566402

CC(c1ccccc1)N1C(=O)c2ccc(O)c(O)c2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 3/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 2/20 0.45
CYP3A4 P08684 2/20 0.45
ALOX15 P16050 2/20 0.45
MAOA P21397 2/20 0.45
APEX1 P27695 2/20 0.45
MAPK1 P28482 2/20 0.45
RECQL P46063 2/20 0.45
KMT2A Q03164 2/20 0.45
BCL2 P10415 1/20 0.45
ALOX12 P18054 1/20 0.45
DAPK1 P53355 1/20 0.45
MCL1 Q07820 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP1B1 Q16678 1/20 0.45
UTS2R Q9UKP6 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19425897 0.81 KDM4E (0.44) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL6101023 0.78 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EMAPTMEN1
SCHEMBL13878053 0.77 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EMAPTMAPK1
SCHEMBL6925572 0.77 LMNA (0.58) ALDH1A1HPGDLMNAPTGESDNMT3A
SCHEMBL607042 0.77 LMNA (0.58) ALDH1A1HPGDLMNAPTGESDNMT3A
SCHEMBL29393294 0.77 LMNA (0.58) ALDH1A1HPGDLMNAPTGESDNMT3A
SCHEMBL6101108 0.73 MAPT (0.39) ALDH1A1HPGDMAPTMAPK1TDP1
SCHEMBL6101116 0.73 MAPT (0.39) ALDH1A1HPGDMAPTMAPK1TDP1
SCHEMBL4368104 0.73 KDM4E (0.66) ALDH1A1KDM4EHSD17B10MAPTMEN1
SCHEMBL13923575 0.73 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009026248-A2 HYDRAZIDE, AMIDE, PHTHALIMIDE AND PHTHALHYDRAZIDE ANALOGS AS INHIBITORS OF RETROVIRAL INTEGRASE THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH, OFFICE OF TECHNOLOGY TRANSFER (US) 2009-02-26 WO disclosed